PRELUDE CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 131 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$149,024
-13.0%
15,395
-1.5%
0.01%0.0%
Q1 2023$171,217
-24.9%
15,622
+51.7%
0.01%
+66.7%
Q3 2021$228,000
+1325.0%
10,300
+836.4%
0.01%
+500.0%
Q3 2020$16,000
+23.1%
1,100
+37.5%
0.00%0.0%
Q2 2020$13,000
-87.1%
800
-84.0%
0.00%
-75.0%
Q4 2019$101,0005,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,969,834$22,667,7521.71%
TANG CAPITAL MANAGEMENT LLC 2,779,500$15,870,9451.62%
Stonepine Capital Management, LLC 300,000$1,713,0001.57%
ARMISTICE CAPITAL, LLC 11,136,000$63,586,5600.80%
Virtus Investment Advisers, Inc. 82,828$472,9480.40%
AlphaCentric Advisors LLC 80,000$456,8000.34%
HighMark Wealth Management LLC 91,196$520,7290.31%
IRONWOOD INVESTMENT MANAGEMENT LLC 89,862$513,1120.27%
Rock Springs Capital Management LP 1,179,740$6,736,3150.20%
683 Capital Management, LLC 400,000$2,284,0000.17%
View complete list of AURINIA PHARMACEUTICALS INC shareholders